关注
Kaushalkumar (Kaushal) Dave, M.Pharm, Ph.D.
Kaushalkumar (Kaushal) Dave, M.Pharm, Ph.D.
在 fda.hhs.gov 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Microneedles in the clinic
S Bhatnagar, K Dave, VVK Venuganti
Journal of Controlled Release 260, 164–182, 2017
2772017
Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules
S Choudhary, L Gupta, S Rani, K Dave, U Gupta
Frontiers in pharmacology 8, 261, 2017
2002017
FDA approval summary: niraparib for the maintenance treatment of patients with recurrent ovarian cancer in response to platinum-based chemotherapy
G Ison, LJ Howie, L Amiri-Kordestani, L Zhang, S Tang, R Sridhara, ...
Clinical Cancer Research 24 (17), 4066-4071, 2018
1132018
Compositions and methods for localized drug delivery through mammary papillae
OP Perumal, K Dave, C Dwivedi, S Santha
US Patent 9,220,680, 2015
592015
Dendritic polymers for dermal drug delivery
K Dave, VV Krishna Venuganti
Therapeutic delivery 8 (12), 1077-1096, 2017
422017
Chemoprevention of breast cancer by transdermal delivery of α-santalol through breast skin and mammary papilla (nipple)
K Dave, FM Alsharif, S Islam, C Dwivedi, O Perumal
Pharmaceutical research 34, 1897-1907, 2017
352017
Transpapillary drug delivery to the breast
K Dave, R Averineni, P Sahdev, O Perumal
PLoS One 9 (12), e115712, 2014
322014
Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis
G Singh, B Ghosh, D Kaushalkumar, V Somsekhar
AAPS PharmSciTech 9 (3), 791-797, 2008
312008
Feasibility of Focused Beam Reflectance Measurement (FBRM) for Analysis of Pharmaceutical Suspensions in Preclinical Development
K Dave, PE Luner, C Forness, D Baker, C Jankovsky, S Chen
AAPS PharmSciTech, 1-11, 2017
182017
Transpapillary (nipple) delivery of macromolecules to the breast: proof of concept study
K Dave, FM Alsharif, O Perumal
Molecular pharmaceutics 13 (11), 3842-3851, 2016
152016
Impact of dendrimers on solubility of hydrophobic drug molecules. Front Pharmacol. 2017; 8: 261
S Choudhary, L Gupta, S Rani, K Dave, U Gupta
142017
Influence of Hydroalcoholic Vehicle on In Vitro Transport of 4-Hydroxy Tamoxifen Through the Mammary Papilla (Nipple)
FM Alsharif, K Dave, AM Samy, KI Saleh, MA Amin, O Perumal
AAPS PharmSciTech 18, 1366-1373, 2017
122017
Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis
TD La Count, Q Zhang, M Murawsky, J Hao, P Ghosh, K Dave, SG Raney, ...
The AAPS journal 22, 1-14, 2020
82020
Assessment of applications of design of experiments in pharmaceutical development for oral solid dosage forms
G Bai, Z Chen, K Raines, H Chen, K Dave, HP Lin, BS Zolnik
Journal of Pharmaceutical Innovation 15, 547-555, 2020
72020
Synthesis and evaluation of esmolol prodrugs for transdermal delivery
G Bijaya, D Kaushal, D Sonal, K Pallavi
Drug Delivery 17 (7), 532-540, 2010
72010
Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products in approved US FDA NDAs designated as Extended-Release or Delayed …
N Ahmed, H Ly, A Pan, B Chiang, K Raines, T Janwatin, S Hamed, ...
European Journal of Pharmaceutics and Biopharmaceutics 193, 294-305, 2023
32023
A Review of In-Vitro Drug Release Methodologies for Topical and Transdermal Systems/Patches provided in NDA and ANDA Submissions to the US-FDA
K Dave, O Anand, E Chikhale, O Eradiri, A Dorantes
2017 Controlled Release Society Annual Meeting, 2017
2017
Topical Drug Delivery to the Breast
K Dave
South Dakota State University, 2015
2015
65th FLAX INSTITUTE OF THE UNITED STATES
H Inn
2014
South Dakota State University, Winter 2014
C Delfanian, E Landwehr
Office of University Relations, South Dakota State University, 2014
2014
系统目前无法执行此操作,请稍后再试。
文章 1–20